Can Acid Pocket-targeting Alginate-antacid (Gaviscon Double Action) Relieve Upper Gastrointestinal Symptoms in Gastro-oesophageal Reflux Disease?

Sung Eun Kim; Moo In Park

doi:10.4166/kjg.2014.63.6.386

Journal List > Korean J Gastroenterol > v.63(6) > 1007250

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim and Park: Can Acid Pocket-targeting Alginate-antacid (Gaviscon Double Action) Relieve Upper Gastrointestinal Symptoms in Gastro-oesophageal Reflux Disease?

Research Update

Korean J Gastroenterol 2014;63(6):386-388.

Published online: 4 October 2014

DOI: https://doi.org/10.4166/kjg.2014.63.6.386

Can Acid Pocket-targeting Alginate-antacid (Gaviscon Double Action) Relieve Upper Gastrointestinal Symptoms in Gastro-oesophageal Reflux Disease?

Sung Eun Kim, Moo In Park

Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea

Correspondence to: Moo In Park, Department of Internal Medicine, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 602-702, Korea. Tel: +82-51-990-6719, Fax: +82-51-990-5055, E-mail: mipark@kosinmed.or.kr

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

Randomised Clinical Trial: Relief of Upper Gastrointestinal Symptoms by an Acid Pocket-targeting Alginate-antacid (Gaviscon Double Action) – a Double-blind, Placebo-controlled, Pilot Study in Gastro-oesophageal Reflux Disease

References

1. Kahrilas PJ, McColl K, Fox M, et al. The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol. 2013; 108:1058–1064.

2. Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: algi-nate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 2000; 14:669–690.

3. Thomas E, Wade A, Crawford G, Jenner B, Levinson N, Wilkinson J. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) – a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2014; 39:595–602.

4. Jung HK, Hong SJ, Jo YJ, et al. Korean Society of Neurogastroenterology and Motility. Updated guidelines 2012 for gastroesophageal reflux disease. Korean J Gastroenterol. 2012; 60:195–218.

5. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012; 24:229–234. e106.

6. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009; 43:111–117.

7. Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology. 2001; 121:775–783.

8. Clarke AT, Wirz AA, Seenan JP, Manning JJ, Gillen D, McColl KE. Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic. Gut. 2009; 58:904–909.

9. Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut. 1999; 44:476–482.

10. Han SH, Hong SJ. Transient lower esophageal sphincter relaxation and the related esophageal motor activities. Korean J Gastroenterol. 2012; 59:205–210.

11. Sweis R, Kaufman E, Anggiansah A, et al. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther. 2013; 37:1093–1102.

TOOLS

Similar articles